CVM•benzinga•
CEL-SCI Announces Final Stages For 212-Patient Confirmatory Registration Study Of Multikine In Advanced Head And Neck Cancer To Confirm Phase 3 Efficacy And Safety Results
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 20, 2025 by benzinga